[HTML] lww.com

[HTML][HTML] Hyperprolactinemia in clinical non-functional pituitary macroadenomas: a STROBE-compliant study

L Lyu, S Yin, Y Hu, C Chen, Y Jiang, Y Yu, W Ma… - Medicine, 2020 - journals.lww.com
Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …
被引用次数：12 相关文章

Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBE-compliant study.

L Lyu, S Yin, Y Hu, C Chen, Y Jiang, Y Yu, W Ma… - Medicine, 2020 - europepmc.org
Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …

Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBE-compliant study

L Lyu, S Yin, Y Hu, C Chen, Y Jiang, Y Yu… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …
[HTML] nih.gov

[HTML][HTML] Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBE-compliant study

L Lyu, S Yin, Y Hu, C Chen, Y Jiang, Y Yu, W Ma… - Medicine, 2020 - ncbi.nlm.nih.gov
Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …
[HTML] lww.com

[HTML][HTML] Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBE-compliant study

L Lyu, S Yin, Y Hu, C Chen, Y Jiang, Y Yu, W Ma… - Medicine, 2020 - journals.lww.com
Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …
[PDF] archive.org

[PDF][PDF] Hyperprolactinemia in clinical non-functional pituitary macroadenomas

L Lyu, S Yin, Y Hu, C Chen, Y Jiang, Y Yu, W Ma… - 2020 - scholar.archive.org
Hyperprolactinemia is a prevalent endocrine disorder presented in patients with non-
functional pituitary adenomas (NFPAs). However, the mechanism involved in …